Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review).
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review).
- Published In:
- International journal of oncology, 66(6) (2025)
- Authors:
- Feng, Hua, Jin, Yuanting, Wu, Bin
- Database ID:
- RPEP-10925
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10925APA
Feng, Hua; Jin, Yuanting; Wu, Bin. (2025). Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review).. International journal of oncology, 66(6). https://doi.org/10.3892/ijo.2025.5749
MLA
Feng, Hua, et al. "Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review).." International journal of oncology, 2025. https://doi.org/10.3892/ijo.2025.5749
RethinkPeptides
RethinkPeptides Research Database. "Strategies for neoantigen screening and immunogenicity valid..." RPEP-10925. Retrieved from https://rethinkpeptides.com/research/feng-2025-strategies-for-neoantigen-screening
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.